Cataract Surgery News

LAS VEGAS – A variety of glaucoma and cataract technologies in the pipeline now will help optometric patients in the future, Justin A. Schweitzer, OD, FAAO, of Vance Thompson Vision Center in Sioux Falls, S.D., said at Vision Expo West.

LAS VEGAS – Optometrists are now able to provide Nd:YAG capsulotomy, laser floater removal, laser peripheral iridotomy and injections with expanded scope of practice in certain states, Nate Lighthizer, OD, FAAO, said at Vision Expo West.

Legislation recently passed by the California Assembly and Senate would allow optometrists in the state to use therapeutic lasers, remove lesions and perform corneal crosslinking.

Corneal hysteresis measurements remained stable in patients with glaucoma during routine follow-up and after cataract surgery over a 6-month period, according to an analysis published in the Journal of Glaucoma.

Office-based surgery is a controversial topic among the ophthalmic community, with some ophthalmologists considering it a feasible option for their practice and investing in office-based suites.

Ocular hypertension is a risk factor for glaucoma, but in the absence of any glaucomatous damage it does not necessitate medical intervention.

Last month, we started a conversation about extended focus IOLs and what makes a patient a good or bad candidate. Looking beyond the patient’s ocular health, one should also consider their profession, personality and hobbies

At the recent American Ophthalmological Society meeting, I had the honor of presenting research on crystalline lens anatomy, including new parameters that can’t be measured with conventional biometry.

Eyes with pseudoexfoliation syndrome were more likely to demonstrate a hyperopic shift and greater anterior chamber deepening after phacoemulsification compared with eyes without pseudoexfoliation, according to a study.

Positive top-line results were reported for a phase 3 clinical study investigating APP13007 to treat inflammation and pain after cataract surgery, according to a press release from Formosa Pharmaceuticals and AimMax Therapeutics.